Rigel Pharmaceuticals Inc (RIGL)
SBC to Revenue
8.70%
Quarterly · Period ending:
RIGL SBC to Revenue
Latest reported8.70%period ending
Latest reported8.70%period ending
RIGL Quarterly SBC/Revenue (0.00% → 8.70%)
Latest values, visible window
High-resolution chart · PNG
RIGL sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 8.696% | |
| 5.8758% | |
| 3.9368% | |
| 4.8415% | |
| 3.2217% | |
| 6.2325% | |
| 3.6235% | |
| 4.7806% | |
| 6.8619% | |
| 17.3834% | |
| 5.4006% | |
| 6.9062% | |
| 8.0786% | |
| 10.5792% | |
| 7.9566% | |
| 12.0794% | |
| 8.0184% | |
| 19.1634% | |
| 11.4606% | |
| 10.2214% | |
| 8.7794% | |
| 3.2573% | |
| 8.8455% | |
| 10.2453% | |
| 10.9669% | |
| 3.6298% | |
| 9.1623% | |
| 10.059% | |
| 25.4925% | |
| 23.392% | |
| 5.4336% | |
| 61.5622% | |
| 62.2272% | |
| 0% | |
| 0% | |
| 97% | |
| 0% | |
| 26.6462% | |
| 88.8667% | |
| 32.3138% | |
| 23.435% | |
| 28.5942% | |
| 19.0348% | |
| 13.9658% | |
| 36.8248% | |
| 94.3067% | |
| 38.9212% | |
| 0% | |
| 0% | |
| 0% | |
| 27.1826% | |
| 0% | |
| 124.7857% | |
| 0% | |
| 0% | |
| 0% | |
| 200.7333% | |
| 413.0667% | |
| 0% | |
| 70.9529% | |
| 810.1266% | |
| 0% | |
| -3.0408% | |
| 5.2115% | |
| 7.4833% | |
| 158.4483% | |
| 504.1333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 99.1679% | |
| 402.1419% | |
| 0% | |
| 0% | |
| 35.9806% | |
| 0.4983% | |
| 0% | |
| 0% | |
| 0.2292% | |
| 11.5455% | |
| 0% | |
| -54.4721% | |
| 3.6315% | |
| 0% | |
| 0% | |
| -12.3457% | |
| 4.9811% | |
| 0% | |
| 0% | |
| 0% | |
| 11.713% | |
| 55.0952% | |
| 0% |